Average Co-Inventor Count = 3.45
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.) (10 from 119 patents)
2. Ipsen Pharma S.a.s. (4 from 108 patents)
3. Ipsen Pharma (1 patent)
14 patents:
1. 8624037 - Imidazolidine-2,4-dione derivatives and use thereof as a medicament
2. 8188133 - Imidazole derivatives, preparation and user thereof as medicine
3. 8017637 - Inhibitors of cdc phosphatases
4. 7795284 - 4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses
5. 7495021 - Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
6. 7279467 - Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
7. 7196084 - Cdc25 phosphatase inhibitors
8. 7132553 - Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
9. 7091239 - DNA polymerase inhibitors, mikanolide and dihydromikanolide
10. 7034024 - Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
11. 7034025 - Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
12. 6887869 - Mikanolide derivatives, their preparation and therapeutic uses
13. 6846822 - Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension
14. 6767561 - DNA polymerase inhibitors, mikanolide and dihydromikanolide